The molecular epidemiology of human respiratory syncytial virus in a tertiary paediatric hospital between 2020 and 2024
Open Access
- 1 January 2026
- journal article
- Published by AOSIS in Journal of the Colleges of Medicine of South Africa
- Vol. 4 (1) , 13
Abstract
Background: Respiratory syncytial virus (RSV) is a leading cause of respiratory illness in young children, contributing significantly to morbidity and mortality and placing a substantial burden on resource-limited healthcare systems. Molecular epidemiological data from sub-Saharan Africa remain limited. This study aimed to investigate the genetic diversity and evolution of RSV in a paediatric population in Cape Town, South Africa, from September 2020 to June 2024. Methods: Respiratory syncytial virus-positive respiratory samples with a cycle threshold (Ct) < 30 from patients at Red Cross War Memorial Children’s Hospital were sequenced and analysed. Phylogenetic analysis of the partial RSV genome (F and G genes) was conducted using reference sequences derived from a global sequence database. Mutational profiles were assessed for relevance to monoclonal antibody and vaccine effectiveness. Results: Of the 100 selected samples, 42 were sequenced, and 40 had sufficient coverage for analysis. Sequencing failure was associated with higher Ct values, older sample age and suboptimal storage at −20°C. Respiratory syncytial virus-A predominated (78.6%), with A.D.5.1 as the dominant lineage; RSV-B strains (16.7%) clustered within B.D.E.1 and B.D.4.1. Genotypes GA2.3.5 (RSV-A) and GB5.0.5a (RSV-B) were observed, consistent with post-pandemic global trends. G-gene analysis revealed multiple substitutions (G224E, I134K, K262E) suggestive of immune pressure. The F-gene remained more conserved; substitutions such as T122A, S211N and S389P were detected but were not linked to reduced susceptibility to monoclonals. Conclusion: This study demonstrated the co-circulation of genetically diverse RSV-A and RSV-B lineages in children between 2020 and 2024. No established resistance-associated substitutions to currently licensed RSV monoclonal antibodies were identified. Continued genomic surveillance is warranted to monitor RSV evolution. Contribution: Continued genomic surveillance is essential to strengthen molecular epidemiology and guide public health preparedness.Keywords
This publication has 29 references indexed in Scilit:
- Whole genome molecular analysis of respiratory syncytial virus pre and during the COVID-19 pandemic in Free State province, South AfricaVirus Research, 2024
- Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID‐19 pandemicJournal of Medical Virology, 2023
- A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial virusesJournal of Clinical Virology, 2023
- Next-generation sequencing of human respiratory syncytial virus subgroups A and B genomesJournal of Virological Methods, 2022
- Determination of genetic characterization and circulation pattern of Respiratory Syncytial Virus (RSV) in children with a respiratory infection, Tehran, Iran, during 2018-2019Virus Research, 2021
- Influenza lineage extinction during the COVID-19 pandemic?Nature Reviews Microbiology, 2021
- A systematic review on global RSV genetic data: Identification of knowledge gapsReviews in Medical Virology, 2021
- Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010–2015Journal of Infection, 2019
- Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17Scientific Reports, 2019
- Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G geneScientific Reports, 2016